360 High-Risk Vulnerability Immunization Tool V2.0 vs Action1 Free Initial Vulnerability Assessment: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Action1 Free Initial Vulnerability Assessment

Startups and SMBs with constrained budgets who need real vulnerability visibility without waiting for scan cycles should start with Action1 Free Initial Vulnerability Assessment; unlimited endpoint assessment plus automated patching for the first 200 machines means you're actually closing gaps, not just logging them. The private software repository hits 99% patching coverage and integrates CISA KEV data, so you're tracking what matters. This is not the tool for organizations that need vulnerability context beyond Windows and third-party apps, or teams expecting deep asset-layer remediation workflows; Action1 is deliberately focused on rapid detection and patch execution.